Intermittent letrozole as adjuvant treatment in postmenopausal hormone-receptor positive early breast cancer patients

被引：0
|
作者：
Balduzzi, A.
Bagnardi, V.
Volpe, S.
Cancello, G.
Iorfida, M.
Dellapasqua, S.
Sandri, M.
Goldhirsch, A.
Colleoni, M.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-13-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-13-12
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors
    El Gharib, Khalil
    Macaron, Walid
    Kattan, Joseph
    Salloum, Mohamad Ali
    Farhat, Fadi
    Smith, Marianne
    El Karak, Fadi
    CURRENT PROBLEMS IN CANCER, 2022, 46 (03)
  • [22] Changing paradigms in the treatment of hormone-receptor positive advanced breast cancer
    Filippi, Roberto
    Montemurro, Filippo
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (08) : 1039 - 1041
  • [23] Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment
    Jung, Yongsik
    Lee, Soo Jung
    Lee, Juneyoung
    Noh, Woo Chul
    Nam, Seok Jin
    Park, Byeong-Woo
    Bae, Young Tae
    Kang, Sung-Soo
    Parks, Heung Kyu
    Yoon, Jung-Han
    Kim, Je Ryong
    Cho, Se Hun
    Kim, Lee Su
    Moon, Byung In
    Jung, Sung Hoo
    Lim, Chol Wan
    Kim, Sung Yong
    Park, Ho Yong
    Song, Jeongyoon
    Lee, Kwang Man
    Park, Sung Hwan
    Jeong, Joon
    Park, Hae Lin
    Kim, Sung Won
    Kwak, Beom Seok
    Kang, Sun Hee
    Cho, Young Up
    Gwak, Geum Hee
    Park, Yong Lae
    Kim, Sang Wook
    Han, Sehwan
    JOURNAL OF BREAST CANCER, 2018, 21 (02) : 182 - 189
  • [24] Cost-effectiveness of adjuvant radiotherapy for older women with early hormone-receptor positive breast cancer.
    Reeder-Hayes, Katherine Elizabeth
    Wheeler, Stephanie B.
    Biddle, Andrea K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining
    Urquhart, Alexander
    Borges, Virginia
    Rabinovitch, Rachel
    Singh, Meenakshi
    Robinson, William
    Seligman, Paul
    Arya, Jyoti
    Finlayson, Christina
    Elias, Anthony
    ONCOLOGY-NEW YORK, 2005, 19 (03): : 278 - +
  • [26] Everolimus in metastatic hormone-receptor positive Breast Cancer
    Richter-Ehrenstein, C.
    ONKOLOGE, 2012, 18 (05): : 435 - +
  • [27] Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer
    Bui, Kim Tam
    Willson, Melina L.
    Goel, Shom
    Beith, Jane
    Goodwin, Annabel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (03):
  • [28] Enhancing the Adjuvant Treatment of Hormone Receptor Positive Breast Cancer
    Barry, Mitchel
    Kell, Malcolm R.
    BREAST JOURNAL, 2009, 15 (02): : 194 - 198
  • [29] Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy for postmenopausal women with early hormone-receptor positive breast cancer - an evaluation of the ATAC-trial.
    Lundkvist, J.
    Paulsson, T.
    Borgstrom, F.
    Kasteng, F.
    Sobocki, P.
    Lidgren, M.
    Henriksson, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S229 - S229
  • [30] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer
    Delea, Thomas E.
    Karnon, Jon
    Sofrygin, Oleg
    Thomas, Simu K.
    Papo, Natalie L.
    Barghout, Victoria
    CLINICAL BREAST CANCER, 2007, 7 (08) : 608 - 618
12345